Current treatment patterns in non-melanoma skin cancer across Europe

Journal of Dermatological Treatment

Volumn 14, Issue SUPPL. 3, 2003, Pages 3-10

  Schmook, T ^a   Stockfleth, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

5 fluorouracil; Actinic keratosis; Basal cell carcinoma; Cryotherapy; Curettage; Imiquimod 5 ; Non melanoma skin cancer; Photodynamic therapy (PDT); Squamous cell carcinoma

Indexed keywords

2 HYDROXYACID; AMINOLEVULINIC ACID METHYL ESTER; CALCITRIOL; DICLOFENAC; FLUOROURACIL; IMIQUIMOD; IMMUNOMODULATING AGENT; INTERFERON; PHOTOSENSITIZING AGENT; RETINOID; SALICYLIC ACID; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BLISTER; BOWEN DISEASE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMOSURGERY; CREAM; CRYOTHERAPY; CURETTAGE; DISEASE SEVERITY; EDEMA; ERYTHEMA; EUROPE; HAIR LOSS; HUMAN; IMMUNOMODULATION; LOW LEVEL LASER THERAPY; NON MELANOMA SKIN CANCER; PAIN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SKIN CANCER; SKIN INFLAMMATION; SKIN PIGMENTATION; SKIN SCAR; SKIN ULCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNBURN; TISSUE INJURY; TREATMENT OUTCOME;

EID: 0344873581     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/jdt.14.s3.3.10     Document Type: Article

References (23)

1. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA, Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer (1999) 81: 555-9.
2. Holme SA, Malinovszky K, Roberts DL, Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol (2000) 143: 1224-9.
3. Plesko I, Severi G, Obsitnikova A, Boyle P, Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Neoplasma (2000) 47: 137-42.
4. Hannuksela-Svahn A, Pukkala E, Karvonen J, Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 135: 781-6.
5. Wassberg C, Thorn M, Johansson AM, Bergstrom R, Berne B, Ringborg U, Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol (2001) 81: 268-72.
6. Staples M, Marks R, Giles G, Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer (1998) 78: 144-8.
7. Salasche SI, Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol (2000) 42(1 Pt 2): 4-7.
8. Ortonne J-P, From actinic keratosis to squamous cell carcinoma. Br J Dermatol (2002) 146(Suppl 61): 20-3.
9. Chuang TY, Brashear R, Risk factors of non-melanoma skin cancer in United States veterans patients: a pilot study and review of literature. J Eur Acad Dermatol Venereol (1999) 12: 126-32.
10. Stockfleth E, Sterry W, New treatment modalities for basal cell carcinoma. Recent Results Cancer Res (2002) 160: 259-68.
11. Rowe DE, Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol (1995) 13: 617-20.
12. Telfer NR, Colver GB, Bowers PW, Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. Br J Dermatol (1999) 141: 415-23.
13. Basset-Seguin N, Ibbotson S, Emtestam L, Photodynamic therapy using Metvix is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 15(S2): 226.
14. Gupta AK, The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation. Cutis (2002) 70(2 Suppl): 30-6.
15. Lawrence N, Cox SE, Cockerell CJ, Freeman RG, Cruz PD Jr, A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol (1995) 131: 176-81.
16. Levy S, Furst K, Chern W, A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clin Ther (2001) 23: 901-7.
17. Stockfleth E, Ulrich C, Hauschild A, Lischner S, Meyer T, Christophers E, Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 12: 569-72.
18. Marks R, Gebauer K, Shumack S et al, Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multi center 6-week dose response trial. J Am Acad Dermatol (2001) 44: 807-13.
19. Geisse JK, Rich P, Pandya A et al, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol (2002) 47: 390-8.
20. Stockfleth E, Meyer T, Benninghoff B et al, A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol (2002) 138: 1498-502.
21. Pariser DM, Lowe NJ, Stewart DM et al, Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol (2003) 48: 227-32.
22. Soler AM, Warloe T, Berner A, Giercksky KE, A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol (2001) 145: 467-71.
23. Turner RJ, Leonard N, Malcolm AJ, Lawrence CM, Dahl MG, A retrospective study of outcome of Mohs' micrographic surgery for cutaneous squamous cell carcinoma using formatin fixed sections. Br J Dermatol (2000) 142(4): 752-7.